The discovery of GLP-1 may offer even better appetite suppression than Ozempic
Ozempic’s maker, Novo Nordisk, says it has developed a compound that has been shown to be a one-stop-shop for appetite suppression and weight loss in mice. Ozempic promotes weight loss by mimicking the GLP-1 hormone that the body naturally produces after eating, so users feel fuller for longer. This potential new therapy harnesses the power … Read more